Lingrui Biotech provides automatic injectors, including both single-use and reusable injection pens, primarily focusing on drug delivery devices for diabetes and obesity patients. The company specializes in developing multi-dose injector pens and disposable auto-injectorsubcutaneous systems, ensuring high precision and reliability in the administration of GLP-1 and insulin medications.

Additionally, Lingrui Biotech offers semi-automatic assembly equipment for auto-injector pens, reusable insulin pens, and drug-delivery systems testing equipment, allowing for efficient production and assembly of injection pens. The company also provides solutions for the semi-automatic assembly of injectors and drugs, catering to the needs of pharmaceutical manufacturers and ensuring seamless integration between drug and injection devices.

Lingrui’s capabilities extend to ODNmulti-dose injector OEM services, delivering customized solutions for different pharmaceutical applications. Moreover, Lingrui focuses on the design and manufacturing of GLP-1 pen injectors, including both disposable and reusable options, ensuring a versatile approach to drug administration for both chronic GLP-1 injections and GLP-1 subcutaneous pen injectors.

With expertise in auto-injector assembly equipment and auto-injector Drug auto-injector OEM, Lingrui continues to provide state-of-the-art devices that improve patient experience and enhance medication delivery effectiveness.